Drug treatment of spasticity and rigidity.
D000547:Amantadine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001418:Baclofen / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003975:Diazepam / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D008615:Mephenesin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009127:Muscle Rigidity / Q000188:drug therapy*; D010276:Parasympatholytics / Q000494:pharmacology / Q000627:therapeutic use; D010636:Phenols / Q000494:pharmacology; D010640:Phenothiazines / Q000627:therapeutic use; D013035:Spasm / Q000188:drug therapy*; D013126:Spinal Nerve Roots / Q000187:drug effects
D010276:Parasympatholytics; D010636:Phenols; D010640:Phenothiazines; D007980:Levodopa; D008615:Mephenesin; D000547:Amantadine; D001418:Baclofen; D003975:Diazepam